ABSTRACT 23
Staphylococcus aureus and other bacterial pathogens affix wall teichoic acids (WTAs) to 24 their surface. These highly abundant anionic glycopolymers have critical functions in bacterial 25 physiology and their susceptibility to β-lactam antibiotics. The membrane-associated TagA 26 glycosyltranserase (GT) catalyzes the first-committed step in WTA biosynthesis and is a founding 27 member of the WecB/TagA/CpsF GT family, more than 6,000 enzymes that synthesize a range 28 of extracellular polysaccharides through a poorly understood mechanism. Crystal structures of 29
TagA from T. italicus in its apo-and UDP-bound states reveal a novel GT fold, and coupled with 30 biochemical and cellular data define the mechanism of catalysis. We propose that enzyme activity 31 is regulated by interactions with the bilayer, which trigger a structural change that facilitates proper 32 active site formation and recognition of the enzyme's lipid-linked substrate. These findings inform 33 upon the molecular basis of WecB/TagA/CpsF activity and could guide the development of new 34
anti-microbial drugs. 35 enzymes are highly conserved in bacteria, they can be expected to operate through a similar 48 mechanism. The results of this work provide insight into WTA biosynthesis and could lead to 49 innovative approaches to treat infections caused by pathogenic bacteria. 50
INTRODUCTION 51
The thick peptidoglycan (PG) sacculus that surrounds Gram-positive bacteria maintains 52 cellular integrity and is affixed with proteins and glycopolymers that have important roles in 53 microbial physiology and host-pathogen interactions. In Staphylococcus aureus and other Gram-54 positive bacteria, wall teichoic acids (WTAs) are a major component of the cell wall, constituting 55 up to 60% of its dry mass (1). WTAs have essential functions, including regulating PG 56 biosynthesis, morphogenesis, autolysin activity, immune evasion, resistance to host cationic 57 antimicrobial peptides, and pathogenesis (2-9). The WTA biosynthetic pathway has drawn 58 considerable interest as an antibiotic target, as genetically eliminating WTA production in clinically 59
important Methicillin-resistant Staphylococcus aureus (MRSA) re-sensitizes it to b-lactam 60 antibiotics and attenuates its virulence (2, 3). 61
WTA polymers are constructed from polymerized alditol-phosphate subunits that are 62 attached to the cell wall via a disaccharide-containing linkage unit. While the chemical structure 63
of the main chain of the polymer can vary, the structure of the linkage unit is highly conserved 64 across different species of Gram-positive bacteria and is composed of an N-acetylmannosamine 65 (ManNAc) (b1→4) N-acetylglucosamine (GlcNAc) disaccharide appended to one to three 66 glycerol-3-phosphate (GroP) groups (10) (Fig. 1A) . The linkage unit performs a key function in 67 WTA display, connecting the WTA polymer to the C6 hydroxyl of PG's N-acetylmuramic acid 68 (MurNAc) (11). WTA is synthesized on the cytoplasmic face of the cell membrane by modifying a 69 membrane-embedded undecaprenyl-phosphate (C 55 -P) carrier. In Bacillus subtilis and S. aureus, 70 the conserved GlcNAc-ManNAc-GroP linkage unit is first synthesized by the sequential action of 71 the TagO, TagA, and TagB enzymes (originally designated TarOAB in S. aureus). TagO initiates 72 WTA synthesis by transferring GlcNAc from the UDP-activated sugar to the C 55 -P carrier to 73 produce lipid-a (12). The TagA glycosyltransferase (GT) then appends ManNAc from a UDP-74
ManNAc donor, producing a C 55 -PP-GlcNAc-ManNAc disaccharide-lipid product (lipid-b) (13, 14) . 75 GT-E fold and shed considerable light onto their mechanism of catalysis. We propose that 105 membrane association activates TagA by triggering a unique dimer to monomer quaternary 106 structural change that facilitates lipid-a recognition and the formation of a catalytically competent 107 active site. The results of these structural and mechanistic studies represent a major 108 advancement in our understanding of WTA biosynthesis that could facilitate the discovery of new 109
antibiotics that work by disrupting the synthesis of this important bacterial surface polymer. 110
111

RESULTS AND DISCUSSION 112
WecB/TagA/CpsF Enzymes are Structurally Novel Glycosyltransferases. To gain insight into 113 the mechanism of catalysis, we determined the 2.0 Å crystal structure of the TagA enzyme from 114
Thermoanaerobacter italicus (TagA DC , residues Met1-Gly195) (Fig. 1b) . TagA DC contains the 115 highly conserved amino acid region that defines the WecB/TagA/CpsF family (Fig. S1 ), but lacks 116 49 C-terminal residues that target the protein to the membrane (vide infra). TagA DC is much better 117 suited for structural analyses, since unlike the full-length protein, it does not require high 118 concentrations of salt and glycerol to be solubilized. Selenomethionine (SeMet)-labeled TagA DC 119 in its apo-form crystallized in the P2 1 space group as a dimer, with eight molecules per asymmetric 120 unit. The structure was determined using the multiple anomalous dispersion (MAD) method and 121 is well-defined by continuous electron density. The subunits in the dimer are related by two-fold 122 non-crystallographic symmetry and possess similar atomic structures; their heavy atom 123 coordinates can be superimposed with an RMSD of 0.11 Å. Complete data collection and 124 structural statistics are provided in Table 1 . 125
TagA adopts a unique a/b tertiary structure that differs markedly from previously described 126 regions (Fig. 1c) . The N-terminal region of TagA is formed by helices H2 to H4 that pack against 128 a b-hairpin constructed from strands b1 and b2, while its larger C-terminal region is comprised of 129 Ramachandran generally allowed (%) 0.9 0.4 Ramachandran outliers (%) 0.0 0.3 a Data from two crystals were merged for structure determination. b Values in parentheses are for highest-resolution shell. c Rfree calculated using 5% of the data.
130
a six-stranded parallel b-sheet (b-strands b4, b3, b8, b7, b5, and b6) that is surrounded by seven 131 helices (helices H1, H3, and H5 to H9). The arrangement of the six parallel strands forming the 132 b-sheet resembles a Rossmann fold commonly found in nucleotide-binding proteins. The regions 133 are interconnected, with the N-terminal b-hairpin forming a single backbone-backbone hydrogen 134 bond to strand b4 within the C-terminal region (between the amide of Asp13 (b2) and the carbonyl 135 of Asn63 (b3)). In the dimer, the C-terminal helix H8 in one subunit packs against helices H2 and 136 H4 located in the N-terminal region of the adjacent protomer, burying 1,226 Å 2 of solvent 137 accessible surface area to produce a narrow pore (Fig. 1d) . Analytical ultracentrifugation (AUC) 138 experiments indicate that TagA DC dimerizes in solution with relatively weak affinity, with a 139 monomer-dimer dissociation constant (K d ) of only 7.4 ± 0.7 μM (Fig. S3A) . As WecB/TagA/CpsF 140 enzymes exhibit related primary sequences, it is expected that they will adopt tertiary structures 141 that are similar to that observed for TagA. coordinates of a subset of residues within the TagA DC and DUF1792 structures can be 154 superimposed with an RMSD of 3.7 Å (Fig. S2A) . However, consistent with these enzymes 155 sharing only 15% sequence identity, the arrangement, number, and topology of their secondary 156 structural elements are distinct (Fig. S2B) . Furthermore, the enzymes have different catalytic 157 mechanisms, as TagA exhibits ion-independent glycosyltransferase activity and it lacks the 158 conserved Asp-X-Glu motif present in DUF1792 that coordinates an Mn 2+ ion cofactor (14). Thus, 159
TagA and related members of the WecB/TagA/CpsF family adopt a novel glycosyltransferase 160 fold, which we term GT-E. 161 162 Active site architecture. To define the enzyme active site, we determined the structure of the 163
TagA
DC :UDP complex at 3.1 Å resolution (Fig. 2a) . The crystal structure visualizes the enzyme-164 product complex, as steady-state kinetics studies of B. subtilis TagA have shown that the enzyme 165
operates via an ordered Bi-Bi mechanism in which UDP-ManNAc binds first and UDP is released 166 last (14). The complex crystallizes as a dimer of trimers in the P2 1 space group, with six molecules 167 in each asymmetric unit (Fig. S4) . The coordinates of the apo-and UDP-bound forms of TagA and-key mechanism. In each protomer, UDP contacts the b7-H8 motif within the Rossmann-like 170 fold, as well as the C-terminal edge of strand b5 (Fig. 2a) . The uracil base is engaged in pi 171 stacking with Tyr137 (b6-H7 loop), while Asp191 (H9) contacts the ribose sugar. The trimeric 172 oligomer observed in the structure of the complex is presumably an artifact of crystallization, as 173 AUC experiments performed in the presence of saturating amounts of UDP indicate that similar 174 to apo-TagA DC , the UDP-bound protein fits best to a monomer-dimer equilibrium model rather 175 than monomer-trimer or dimer-trimer equilibrium models (K d = 3.5 ± 0.4 μM in the presence of 176 10:1 UDP:TagA) (Fig. S3B) . In the complex, each UDP molecule is primarily contacted by a single 177 subunit. However, the C2 hydroxyl group in each UDP molecule forms a hydrogen bond with the 178 backbone carbonyl of Val192 (H9) located in the adjacent subunit, which may explain why the 179 complex crystallized as a trimer. 180 Intriguingly, positioned immediately adjacent to the UDP binding site on each protomer is 182 a large pocket that harbors several phylogenetically conserved amino acids that are important for 183 catalysis (Fig. 2b) . The pocket resides near the C-terminal end of the parallel b3 and b8 strands 184 and has walls that are formed by residues located in helices H5 and H8, as well as residues within 185 the polypeptide segments that connect strand b7 to helix H8, and strand b3 to helix H2. Several 186 highly-conserved residues are located within the pocket and its periphery, including Thr37, Asn39, 187
Asp65, Arg83, Gln167, and Glu168 (Figs. 2a and S1 ). Interestingly, in the crystal structure of the 188 TagA analysis reveals that only the full length TagA protein is enzymatically active in vitro, while the 214 truncated TagA DC protein used for crystallography and modeling is catalytically inactive (Fig. 2d) . 215 This is compatible with the high level of primary sequence conservation of C-terminal residues 216 within WecB/TagA/CpsF enzymes and suggests that the deleted appendage may be necessary 217 to construct a catalytically competent active site (Fig. S1 ). To gain insight into the function of the 218 appendage, we utilized the structure of the TagA protein modeled using Generative Regularized 219
Models of Proteins (GREMLIN), a recently developed protein modeling server that predicts tertiary 220 structure by exploiting sequence conservation and amino acid co-evolutionary patterns (40, 41). 221
Only GREMLIN-predicted structures in which TagA was assumed to be monomeric yielded 222 favorable results, and is substantiated by important correlations between residues within the body 223 of TagA DC and the appendage (in T. italicus: Arg83 and Arg205, Ala72 and Val235, Gln47 and 224
Lys234, Val197 and Glu218/Lys217, and Lys198 and Lys217 couplings). In general, the tertiary 225 structures of the GREMLIN-predicted model of monomeric TagA (TagA GM ) and the experimentally 226 determined crystal structures of TagA DC are similar. However, only in TagA GM is the C-terminal 227 appendage present, which forms three a-helices (H10 to H12) that pack against the active site 228 harboring the catalytically important Asp65 and Thr37 residues. The C-terminal appendage is 229 presumably unstructured in dimeric forms of the enzyme, as, importantly, the contact surface 230 The TagA GM monomer provides insight into why the C-terminal appendage is critical for 234 catalysis, as it contains several highly-conserved arginine residues that project side chains into 235 the enzyme's active site (Arg214, Arg221 and Arg224) (Fig. 3a) . Of particular interest is the side 236 chain of Arg221 within helix H11 of the appendage, as modeling of TagA GM bound to its substrates 237 suggests that the Arg221 guanidino group may stabilize the b-phosphate of the UDP leaving 238 group (Fig. 4a) . Indeed, Arg221Glu mutation in TagA significantly abates TagA GT activity, 239 strongly suggesting that only the monomeric form of TagA is enzymatically active (Fig. 2d ). While 240 not tested in this study, the side chains of Arg214 and Arg224 may also be important for catalysis, 241
as some cation-independent GTs use more than one positively charged residue to stabilize 242 phosphotransfer reaction intermediates (42). Chemical crosslinking studies of cells expressing 243 full length T. italicus TagA indicate that the protein forms a mixture of monomers and dimers (Fig.  244   S3C) , consistent with the relatively weak dimerization affinity of TagA DC measured by AUC (Fig  245   S3A and S3B) . Thus, in the cell, TagA presumably toggles between distinct oligomeric states: 1) 246 enzymatically active monomers, in which the C-terminal appendage contributes key residues to 247 the active site, and 2) inactive dimers, in which inter-subunit interactions mask an incompletely 248 formed active site. bilayer. In monomeric TagA GM , helices H11 and H12 within the C-terminal appendage project 255 several non-polar side chains into the solvent for potential membrane interactions (e.g. Leu212, 256
Ile216, Ile233, in T. italicus TagA) (Fig. 3b) (43-47) . To investigate the role of the C-terminal 257 appendage in membrane binding, we determined how this structural element affected TagA 258 localization in B. subtilis, since unlike T. italicus, robust tools are available to genetically 259 manipulate this model Gram-positive bacterium. Importantly, the TagA homologs in these 260 organisms are related (34% sequence identity) and both contain the conserved C-terminal 261 appendage (Fig. S1) . B. subtilis cells expressing hexahistidine-tagged TagA ( Bs TagA) were 262 fractionated and analyzed by Western blotting.
Bs TagA peripherally associates with the 263 membrane, since it is present in the membrane fraction, but released into the soluble fraction after 264 adding either potassium hydroxide or the chaotropic salt sodium iodide ( Fig. 3c and 3d,  265 respectively). Interestingly, TagA lacking the C-terminal appendage ( Bs TagA DC , residues Met1-266
Val196) primarily partitions into the soluble fraction, indicating that this structural element tethers 267 the protein to the membrane (Fig. 3c) . Other bacterial enzymes are targeted to the membrane 268 via terminal helices (e.g. TagB, FtsA, MinD, PBP enzymes), but TagA is novel because its helices 269 form an integral part of the active site (43-47). 270
Collectively, our data suggest that TagA is activated through a unique membrane-271 association mechanism that is mediated by residues at its C-terminus. TagA is in equilibrium 272 between monomeric and dimeric states. Removed from the membrane, it is primarily dimeric with 273 interfacial interactions obstructing the binding site for its C-terminal appendage and holding the 274 enzyme in an inactive, dimeric state (Fig. 4B) . However, upon encountering the membrane, we 275 posit that non-polar side chains within the appendage are inserted into the bilayer, thereby 276 nucleating its folding and the formation of a monomeric, catalytically functional enzyme in which 277 the appendage contributes key active site residues. In the TagA GM monomer, a gap is located 278 between helices H11 and H12 in the C-terminal appendage, forming a short pore that connects 279 the active site to the protein's membrane binding surface. Thus, membrane induced folding of the 280 C-terminal appendage may also facilitate recognition of the lipid-a by providing an additional 281 binding site for several of its non-polar prenyl groups. While the catalytic activities of other 283 membrane-associated enzymes are regulated by lipid bilayer-induced quaternary structural 284 changes or allosteric mechanisms, to the best of our knowledge, the TagA activation mechanism 285 outlined here is unique (48). 286
In conclusion, our results provide direct insight into how TagA enzymes synthesize the 287 conserved linkage unit used to attach WTA to the cell wall and, and more generally, how members 288 of the large WecB/TagA/CpsF GT family produce a range of important surface-associated and 289 secreted bacterial glycopolymers. TagA is a structurally unique GT that we propose defines a new 290
GT-E fold. Removed from the membrane, it forms catalytically inactive dimers that are presumably 291 incapable of mediating spurious GT reactions or hydrolyzing UDP-ManNAc. However, upon 292 encountering the membrane containing its lipid-a substrate, conserved C-terminal residues in 293
TagA fold into an essential active site appendage, stabilizing the monomeric and catalytically-294 active form of the enzyme. From our structural and biochemical data, a working model of the 295 catalytic mechanism can be proposed (Fig. 4C) . Previous studies have shown that catalysis likely 296 occurs via an S N 2-like mechanism that inverts the anomeric stereochemistry of ManNAc (14). It 297 seems likely that Asp65 functions as a base, deprotonating the GlcNAc C4 hydroxyl in lipid-a. 298
This would facilitate its nucleophilic attack at the anomeric carbon of ManNAc, resulting in an 299 oxocarbenium ion-like transition state that is stabilized by electrostatic interactions between 300 Arg221, donated by the C-terminal appendage, and the diphosphate moiety of UDP. Thr37 within 301 the conserved pocket may play an important role in orienting the ManNAc moiety of the sugar 302 donor, poising its electrophilic center for glycosidic bond formation. A complete understanding of 303 the catalytic mechanism will require the structure determination of additional key reaction 304
intermediates. As WTA and other bacterial glycopolymers are critical components of the cell wall, 305 the results of these studies are of fundamental importance and could facilitate the discovery of 306
GT-E (WecB/TagA/CpsF) specific enzyme inhibitors that could be useful antibiotics. 307
MATERIALS AND METHODS 308
Cloning, expression, protein purification, and crystallization. Bacterial strains and plasmids 309 used in this study are listed in SI Materials and Methods, Table I . Protocols for protein purification, 310 crystallization, and structure determination are detailed in SI Materials and Methods. 311
312
Mutagenesis and activity assays. Conservation analysis was conducted using the Consurf 313
Server (49-51). The lipid-⍺ or UDP-ManNAc substrates were generated in silico using the Phenix 314 electronic Ligand Builder and Optimization Workbench (Phenix.eLBOW) (52). Cis-trans 315 configuration and stereochemistry were confirmed or corrected using the Phenix Restraints Editor 316
Especially Ligands (Phenix.REEL). The substrates were docked to the 2.0 Å resolution protomer 317 structure using Autodock vina with a 25 x 25 x 25 Å search space and an exhaustiveness of 18 318 (38). TagA in vitro enzyme activity was determined using an anion-exchange HPLC system and 319 the following assay conditions: 0.2 µM TagA; 100 µM lipid-⍺; 100 µM UDP-GlcNAc; 3 µM MnaA; 320 50 mM Tris-HCl, pH 7.5; and 250 mM NaCl (39). Reactions were incubated for 40 minutes before 321 quenching with 3 M urea. The reactions were separated with a DNAPak PA200 anion-exchange 322 column using a buffer gradient of 100% Buffer A (20 mM NH4HCOO3, and 10% MeCN, pH 8.0) 323 to 90% Buffer A plus 10% Buffer B (20 mM NH4HCOO3, 10% MeCN, and 1 M NaCl, pH 8.0) over 324 10 minutes. UDP-ManNAc or UDP elution peaks were monitored at 271 nm and integrated to 325 determine turnover rate. 326 327 Cell fractionation. Overnight B. subtilis cultures containing selective antibiotics were diluted 328 1:100 into 1 L of fresh LB broth containing 1 mM IPTG. Cultures were incubated at 37°C and 250 329 rpm until an OD 600 of 1.0 was reached. Cells were pelleted at room temperature, washed once 330 with PBS, and then frozen at -80°C. Cells were fractioned as previously reported with several 331 exceptions (47). Cells were re-suspended in 10 mL of Lysis Buffer (PBS, pH 7.3; 1 mM EDTA; 1 332 mM DTT; 10 µg/mL RNase; 10 µg/mL DNase; 2 mM PMSF, and 100 µL Protease inhibitor 333 cocktail) and sonicated on ice for eight minutes, with one minute "on" (one second pulses for 60 334 seconds) and one minute "off" (no pulses for 60 seconds). Ten milliliters of lysate were divided 335 into two 5 mL volumes and centrifuged in a Beckman type 50 TI rotor in a Beckman XPN-100 336 preparative ultracentrifuge. The lysate was centrifuged at 9,600 rpm for 10 minutes to remove 337 cellular debris. The supernatant was collected and centrifuged at 21,000 rpm. The supernatant 338 was removed and spun for a third time at 40,000 rpm for one hour. This final supernatant fraction 339 was considered to be the soluble fraction, and the remaining pellet, which contained the 340 membrane fraction was re-suspended in 1 mL of ice-cold Lysis Buffer. The membrane fraction 341 was diluted ten-fold for comparison with the supernatant and samples were run on an SDS-PAGE 342 gel for 50 minutes at 170 V and transferred to a PVDF membrane using an iBlot transfer device 343 (ThermoFisher Scientific). The membrane was fixed in methanol for five minutes, briefly washed 344 in water, and then blocked over-day in TBST Blocking Buffer (20 mM Tris-HCl, pH 7.5; 500 mM 345 NaCl; 0.05% Tween; and 5% w/v nonfat milk). The membrane was washed, incubated with 346 primary antibody (Invitrogen #MA-21215, mouse anti-6 X His, 1:1000 dilution in TBST Blocking 347
Buffer) overnight at 4°C, washed again, and incubated with secondary antibody (Sigma-Aldrich 348
#A9044, anti-mouse horseradish peroxidase). The membrane was incubated with SuperSignal 349
West Pico Chemiluminescent Substrate (Thermo Scientific #34080) for five minutes and exposed 350 to radiography film for one to ten minutes. 
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Institutes of Health (AI52217 to R.T.C. proposed active site of TagA co-localizes residues D65, T37, and R221. Lipid-a (yellow) is 553 activated by the catalytic base D65 (pink), while ManNAc (green) is positioned by contacts 554 between its C6 hydroxyl and T37 (cyan). The C-terminal helices (tan) are modeled according to 555 GREMLIN structural predictions and place R221 (purple) adjacent to the phosphates of UDP-556
ManNAc (orange) to putatively stabilize the leaving group. (B) The TagA molecular mechanism 557 is proposed to utilize a dimer to monomer transition to regulate glycosyltransferase activity. TagA 558 is stabilized as a soluble dimer. Upon interaction with the cell membrane, the C-terminus adopts 559 an ordered state and disrupts the dimer interface, which produces a competent active site by co-560 localizing D65, T37, and R221 to coordinate the soluble UDP-ManNAc and membrane-bound 561 lipid-a substrates. (C) TagA reveals the catalytic mechanism of the GT26 family. Asp65 activates 562 lipid-a, which proceeds to attack UDP-ManNAc in an S N 2-like mechanism. Coordination between 563
Arg221 and the phosphates of UDP stabilize the leaving group, permitting the oxocarbenium ion-564 like transition state. The mechanism is completed by glycosidic bond-formation between GlcNAc 565
and ManNAc to form lipid-β. 566
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MATERIALS AND METHODS 568
Cloning, expression, and protein purification. The N-terminal domain of TagA from T. italicus 569
(
Ti TagA ΔC , residues Met1-Gly195) or S. aureus ( Sa TagA ΔC , residues Ala10-Ala204) was expressed 570 from a pMAPLe4 plasmid in Escherichia coli BL21(DE3) cells (Table S1 ). Standard methods were 571 employed, with cultures grown in the presence of 50 µM kanamycin at 37°C until an OD 600 of 0.6-572 0.8 was reached. Protein expression was initiated by adding isopropyl-β-D-1-573 thiogalactopyranoside (IPTG) to 1 mM, followed by overnight protein expression at 18°C. A four-574 liter cell culture was harvested by centrifugation at 7000 rpm in a Beckman JA-10 rotor, and the 575 pellet was re-suspended in 40 mL of Buffer A (50 mM Tris, pH 7.5; 500 mM NaCl; 40 mM CHAPS) 576 with 400 µL of protease inhibitor cocktail (Sigma) and 2 mM phenylmethanesulfonylfluoride 577 (PMSF). The cells were then lysed using an EmulsiFlex high pressure homogenizer (Avestin). 578
Cell lysates were fractionated by centrifugation at 15,000 rpm in a Beckman JA-20 rotor, and the 579 soluble portion was applied to a gravity column containing 10 mL of suspended His-Pure Co 2+ 580 resin (Life Technologies) that was pre-equilibrated with Buffer A. The resin was washed with 20 581 mL aliquots of Buffer B (50 mM Tris, pH 7.5; 500 mM NaCl; 0.5% CHAPS) that contained 0, 25, 582 or 50 mM imidazole. His-tagged TagA ΔC was eluted using Buffer B with 500 mM imidazole, and 583 the fractions were pooled and concentrated using a 10 kDa MWCO Amicon Ultra-15 centrifugal 584 filter (Millipore). To remove His 6 -tag from the protein, TEV protease was added to TagA ΔC , and 585 the solution was dialyzed in a 3.5 kDa MWCO Slide-A-Lyzer dialysis cassette (ThermoFisher 586 Scientific) against Buffer C (50 mM Tris, pH 7.5; 200 mM NaCl) at 4 °C overnight. TEV protease 587 was then separated from TagA ΔC by binding 10 mL of suspended His-Pure Co 2+ resin (Life 588 Technologies) that was pre-equilibrated with Buffer C; cleaved TagA ΔC , which lacked the His 6 -tag, 589 was eluted from the resin using Buffer C. Cleaved TagA ΔC was further purified by gel filtration 590 chromatography using a Sephacryl size-exclusion column (GE Healthcare Life Sciences) that wasequilibrated with Buffer C. Purified TagA ΔC was then pooled, concentrated to 55 mg/mL, and 592 stored at 4°C. 593 Selenomethionine (SeMet) labeled protein was prepared with cultures grown in M9 594 minimal media in the presence of kanamycin at 37°C until an OD 600 of 0.6-0.8 was reached. 595
Protein expression was then initiated by adding IPTG to 1 mM followed by overnight protein 596 expression at 18°C. Protein purification was performed as described for native protein. The TagA ΔC crystals diffracted X-rays to 2.0 Å resolution. The XDS/XSCALE package was 610 used to index, integrate and scale data in P2 1 space group (1). The asymmetric unit of the crystal 611 contained eight protein molecules, yielding a Matthews coefficient of 2.11 Å/Da and a 41.79% 612 solvent content in the unit cell. The SHELX suite was used to locate the heavy atom substructure, 613 which identified a total of 56 selenium atom sites (2). The quality of the phases calculated with 614 the peak, inflection, and high remote energy diffraction datasets were improved using SHARP 615 Figure S1 . TagA primary sequence homology. The National Center for Biotechnology Institute's 710
SUPPLEMENTAL FIGURES 709
Basic Local Alignment Tool (BLAST) was used to determine TagA sequence homologs with high 711 sequence identity. The Clustal Omega multiple sequence alignment tool was used to generate a 712 sequence alignment (9). Secondary structure is shown above the sequence and coloring is 713 indicated in the key. 714 UDP, which can be seen at the interface between protomers of the trimer.
738 Table S1 -Strains and plasmids used in this study. 739
Strain
Genotype/Description Source
